Cargando…
Liquid biopsies for multiple myeloma in a time of precision medicine
Multiple myeloma (MM) is a challenging, progressive, and highly heterogeneous hematological malignancy. MM is characterized by multifocal proliferation of neoplastic plasma cells in the bone marrow (BM) and sometimes in extramedullary organs. Despite the availability of novel drugs and the longer me...
Autores principales: | Ferreira, Bruna, Caetano, Joana, Barahona, Filipa, Lopes, Raquel, Carneiro, Emilie, Costa-Silva, Bruno, João, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198642/ https://www.ncbi.nlm.nih.gov/pubmed/32246161 http://dx.doi.org/10.1007/s00109-020-01897-9 |
Ejemplares similares
-
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
por: Lopes, Raquel, et al.
Publicado: (2021) -
Boosting Immunity against Multiple Myeloma
por: Lopes, Raquel, et al.
Publicado: (2021) -
P837: MULTIPLE MYELOMA AND ADJACENT NK CELLS CAN EXPRESS THE MACHINERY TO INTEGRATE NEURONAL SIGNALS
por: Filipa Barahona, Ana, et al.
Publicado: (2023) -
Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study
por: Ferreira, Bruna Velosa, et al.
Publicado: (2022) -
Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment
por: Lopes, Raquel, et al.
Publicado: (2022)